[Astigmatism].

Astigmatismus.
Ocular residual astigmatism Refraction error Tomography Topography Toric intraocular lens

Journal

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 21 2 2019
medline: 28 7 2019
entrez: 21 2 2019
Statut: ppublish

Résumé

Astigmatism is the most frequent refractive error worldwide followed by hyperopia and myopia. Internal astigmatism has to be differentiated from external astigmatism. Furthermore, external astigmatism can be divided into "with the rule", "against the rule" and "oblique". The summation of internal and external astigmatism results in the refractive cylinder. Astigmatism has for a long time been regarded as a two-dimensional phenomenon; however, only a three-dimensional consideration expanded the view on existing analytical methods (topography and tomography). Alpins' vector analysis is a commonly used method for treatment planning. Multiple options exist for treatment of astigmatism with conservative approaches, such as eyeglasses or toric contact lenses as well as various surgical procedures, such as photorefractive keratectomy, femtosecond laser-assisted keratotomy, laser in-situ keratomileusis, small incision lenticule extraction and toric intraocular lens implantation.

Identifiants

pubmed: 30783746
doi: 10.1007/s00347-019-0865-7
pii: 10.1007/s00347-019-0865-7
doi:

Types de publication

Journal Article

Langues

ger

Pagination

293-304

Références

J Cataract Refract Surg. 2001 Jan;27(1):31-49
pubmed: 11165856
Curr Opin Ophthalmol. 2002 Aug;13(4):250-5
pubmed: 12165710
J Vis. 2001;1(1):1-8
pubmed: 12678609
Optom Vis Sci. 2005 Apr;82(4):244-7
pubmed: 15829852
Clin Exp Optom. 2007 Jan;90(1):5-19
pubmed: 17177660
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):73-82
pubmed: 17197519
J Refract Surg. 2007 Nov;23(9):853-67
pubmed: 18041238
J Cataract Refract Surg. 2008 Aug;34(8):1250-9
pubmed: 18655973
J Cataract Refract Surg. 2009 Jan;35(1):70-5
pubmed: 19101427
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):594-601
pubmed: 20019374
J Refract Surg. 2010 May;26(5):321-6
pubmed: 20506988
J Cataract Refract Surg. 2010 Aug;36(8):1323-9
pubmed: 20656155
J Cataract Refract Surg. 2010 Sep;36(9):1479-85
pubmed: 20692558
Surv Ophthalmol. 2010 Nov-Dec;55(6):561-83
pubmed: 20851442
Invest Ophthalmol Vis Sci. 2011 Jun 21;52(7):4350-5
pubmed: 21460261
Korean J Ophthalmol. 2012 Dec;26(6):438-45
pubmed: 23204799
Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1635-9
pubmed: 23456100
Exp Eye Res. 2013 Sep;114:89-95
pubmed: 23644224
Invest Ophthalmol Vis Sci. 2013 Sep 09;54(9):6063-7
pubmed: 23950154
Indian J Ophthalmol. 2013 Nov;61(11):645-8
pubmed: 24145563
J Cataract Refract Surg. 2014 Feb;40(2):232-8
pubmed: 24333012
J Cataract Refract Surg. 2014 Jan;40(1):13-9
pubmed: 24355718
Eur J Ophthalmol. 2014 Jul-Aug;24(4):494-500
pubmed: 24366768
Arq Bras Oftalmol. 2014 Apr;77(2):125-31
pubmed: 25076481
Trans Am Ophthalmol Soc. 1874;2:128-31
pubmed: 25258770
Hum Genet. 2015 Feb;134(2):131-46
pubmed: 25367360
PLoS One. 2015 Apr 15;10(4):e0124313
pubmed: 25875476
J Cataract Refract Surg. 2015 Aug;41(8):1650-7
pubmed: 26432122
Ophthalmologe. 2017 Jun;114(6):549-555
pubmed: 27822628
BMC Ophthalmol. 2016 Dec 1;16(1):212
pubmed: 27905889
Eye Contact Lens. 2018 May;44(3):137-143
pubmed: 27930395
Am J Ophthalmol. 2017 Aug;180:165-177
pubmed: 28647461
BMC Ophthalmol. 2017 Jul 27;17(1):132
pubmed: 28750611
Cochrane Database Syst Rev. 2017 Sep 20;9:CD010510
pubmed: 28931202
Cornea. 2017 Nov;36 Suppl 1:S34-S40
pubmed: 28937417
Eye Vis (Lond). 2017 Dec 6;4:29
pubmed: 29238735
Clin Exp Ophthalmol. 2018 Mar;46(2):133-146
pubmed: 29266624
Mol Vis. 2018 Feb 05;24:127-142
pubmed: 29422769
J Curr Ophthalmol. 2017 Sep 27;30(1):3-22
pubmed: 29564404
Am J Ophthalmol. 1980 Sep;90(3):360-8
pubmed: 7425052
J Cataract Refract Surg. 1997 Jan-Feb;23(1):65-75
pubmed: 9100110
J Cataract Refract Surg. 1998 May;24(5):634-46
pubmed: 9610446
Am J Hum Genet. 1998 Sep;63(3):825-30
pubmed: 9718344

Auteurs

N Woltsche (N)

Univ.-Augenklinik Graz, Medizinische Universität Graz, Auenbruggerplatz 4, 8036, Graz, Österreich. n.woltsche@medunigraz.at.

P Werkl (P)

Univ.-Augenklinik Graz, Medizinische Universität Graz, Auenbruggerplatz 4, 8036, Graz, Österreich.

L Posch-Pertl (L)

Univ.-Augenklinik Graz, Medizinische Universität Graz, Auenbruggerplatz 4, 8036, Graz, Österreich.

N Ardjomand (N)

Sehzentrum für Augenlaser & Augenchirurgie, Leechgasse 58, 8010, Graz, Österreich.

A Frings (A)

Univ.-Augenklinik Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
UCL Institute of Ophthalmology, 11-43 Bath St, EC1V 9EL, London, Großbritannien.
Moorfields Eye Hospital NHS Foundation Trust, 162 City Rd, EC1V 2PD, London, Großbritannien.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH